Democrats Put Paid Family Leave Back in Build Back Better Plan After Committee Compromise

Paid family and medical leave were added back into the $1.75 trillion spending bill after the measures were previously dropped amid negotiations, Democrats said Wednesday, the Associated Press reported.

Democrats reluctantly conceded on the key element as they attempted to scale down the price tag of the sweeping package. But Democratic Representative Richard Neal, chairman of the House Ways and Means Committee, said that the committee had reached a compromise so that they could include a "means-tested program."

"The Ways and Means Committee crafted a policy that will finally give workers and their families the peace of mind of knowing that when disaster strikes, they can rely on paid leave to avoid total crisis," Neal said.

After months of negotiations and changes, Democrats are still working to finalize a package that will be able to pass the Senate and House. House Speaker Nancy Pelosi said that "we must strive to find common ground in the legislation" after an unnamed senator informed her that they were against some of the priorities included in the House bill, AP reported.

For more reporting from the Associated Press, see below.

Paid Family Leave Back in Package
Paid family and medical leave were added back into the $1.75 trillion spending bill after the measures were previously dropped amid negotiations, Democrats said Wednesday. Above, House Speaker Nancy Pelosi arrives to meet with the Democratic Caucus at the Capitol in Washington, D.C., on November 2, 2021. J. Scott Applewhite/AP Photo

Senate Majority Leader Chuck Schumer on Tuesday announced the prescription drug deal on one of the few remaining provisions that needed to be resolved in Biden's big package as the party moves closer to wrapping up negotiations. Schumer acknowledged it's not as sweeping as Democrats had hoped for, but a compromise struck with one key holdout Democrat, Senator Kyrsten Sinema of Arizona.

Democrats are rushing to overcome party battles and finish a final draft of Biden's plan. Pelosi had hoped to wrap up the draft and pave the way for voting as soon as Thursday on the overall package, according to her remarks at a closed-door caucus meeting.

Fingers are pointing all around as negotiations over Biden's ambitious package have dragged on, with Democrats unable to pass the bill. Progressive and centrist lawmakers, particularly Senator Joe Manchin, a West Virginia Democrat, and Sinema, have fought over details of the sprawling 1,600-page package.

"I think what most people think: The situation is like, 'Okay, we elected Democrats to have the majority in the House, the Senate and the presidency. They should be getting things done,'" Democratic Representative Elaine Luria, who represents a swing district in Virginia, told reporters at the Capitol.

Still, Democrats shored up at least one unsettled provision—reviving the prescription drug deal that had been scrapped from Biden's framework.

"It's not everything we all want. Many of us would have wanted to go much further, but it's a big step in helping the American people deal with the price of drugs," Schumer said at the Capitol.

Schumer said that for the first time, Medicare will be able to negotiate prescription drug prices in its Part B and Part D programs. The $2,000 cap on out-of-pocket costs would benefit those older Americans with the Part D prescription drug benefit, who number some 48 million, Democrats said.

And there would be "a new monthly cap on the price of insulin, and an 'inflation' rebate policy to protect consumers from egregious annual increases in prices," Schumer said. The insulin prices would fall from as high as $600 a dose to $35.

The penalties on drug manufacturers for raising prices beyond the inflation rate begin this year.

Sinema's office issued a statement saying the senator "welcomes a new agreement on a historic, transformative Medicare drug negotiation plan that will reduce out-of-pocket costs for seniors."

AARP, the powerful organization for older Americans, signaled support as it waits for details. CEO Jo Ann Jenkins said in a statement there was "no greater issue affecting the pocketbooks of seniors on Medicare than the ever-increasing costs of prescription drugs."

But Pharmaceutical Research and Manufacturers of America president and CEO Stephen J. Ubl said the proposal "gives the government the power to dictate how much a medicine is worth." The pharmaceutical lobby warned it "threatens innovation."

On another issue, Democrats neared agreement on a plan to do away with the $10,000 limit on state and local tax deductions that particularly hits New York, California and other high-tax states and was enacted as part of the Trump-era 2017 tax plan.

While repeal of the so-called SALT deduction cap is a priority for several northeastern state lawmakers, progressives want to prevent the super-wealthy from benefiting. Under an emerging plan, the cap would be repealed from 2021 to 2025, but reinstated from 2027 to 2031, according to a person who requested anonymity to discuss the private talks.

Manchin has been an unreliable partner for Biden's big vision, raising concerns about the president's plans expand health care, child care and other social services and tackle climate change.

A group of House Democrats huddled with the West Virginia senator privately Tuesday at the Senate. He showed no signs of relenting Tuesday, despite widespread criticism over the power of a single senator to hold up the party's signature domestic priority.

"It's going to be a while," Manchin said in brief comments Tuesday at the Capitol.

Representative Pramila Jayapal, a Washington Democrat and the leader of the progressive caucus said, "I don't know what Senator Manchin is thinking, but we are going to pass both bills through the House and we are going to deliver transformative change to the people."

With Republicans staunchly opposed and no votes to spare, Democrats have been trying to unite progressive and centrist lawmakers around Biden's vision.

The $1.75 trillion package would provide large numbers of Americans with assistance to pay for health care, education, raising children and caring for elderly people in their homes. It also would provide some $555 billion in tax breaks encouraging cleaner energy and electrified vehicles, the nation's largest commitment to tackling climate change.

Much of its costs would be covered with higher taxes on people earning over $10 million annually and large corporations, which would now face a 15 percent minimum tax in efforts to stop big business from claiming so many deductions they end up paying zero in taxes.

Some moderate Democrats in the House said they want to see the final assessment from the Congressional Budget Office on its entire budgetary costs, before taking the vote.

Manchin Package Support Wavering
Senator Joe Manchin has been a key Democratic holdout on President Joe Biden's domestic spending package. Above, Manchin is surrounded by reporters after his statement indicating his support for the sweeping policy proposals was wavering, at the Capitol in Washington, D.C., on November 2, 2021. J. Scott Applewhite/AP Photo

Editor's pick

Newsweek cover
  • Newsweek magazine delivered to your door
  • Unlimited access to
  • Ad free experience
  • iOS and Android app access
  • All newsletters + podcasts
Newsweek cover
  • Unlimited access to
  • Ad free experience
  • iOS and Android app access
  • All newsletters + podcasts